The short-term supplementation treatment of vitamin D in T2DM appeared to have a major impact on HbA1c values, with the receptor response reducing insulin resistance and insulin synthesis in T2DM patients, suggesting that vitamin D can be included as additional therapeutic agent in diabetes for patients with obesity. The gene discussed is INS; the disease is obesity disorder.